R
Roman S. Kozlov
Researcher at IAC
Publications - 57
Citations - 3879
Roman S. Kozlov is an academic researcher from IAC. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 10, co-authored 32 publications receiving 2120 citations.
Papers
More filters
Journal ArticleDOI
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Evelina Tacconelli,Elena Carrara,Alessia Savoldi,Stéphan Juergen Harbarth,Marc Mendelson,Dominique L Monnet,Céline Pulcini,Gunnar Kahlmeter,Jan Kluytmans,Yehuda Carmeli,Marc Ouellette,Kevin Outterson,Jean B. Patel,Marco Cavaleri,Edward Cox,Christopher R. Houchens,M Lindsay Grayson,Paul Hansen,Nalini Singh,Ursula Theuretzbacher,Nicola Magrini,Aaron O. Aboderin,Seif Al-Abri,Nordiah Awang Jalil,Nur Benzonana,Sanjay Bhattacharya,Adrian Brink,Francesco Robert Burkert,Otto Cars,Giuseppe Cornaglia,Oliver J. Dyar,Alexander W. Friedrich,Ana Cristina Gales,Sumanth Gandra,Christian G. Giske,Debra A. Goff,Herman Goossens,Thomas Gottlieb,Manuel Guzman Blanco,Waleria Hryniewicz,Deepthi Kattula,Timothy Jinks,Souha S. Kanj,Lawrence Kerr,Marie-Paule Kieny,Yang Soo Kim,Roman S. Kozlov,Jaime Labarca,Ramanan Laxminarayan,Karin Leder,Leonard Leibovici,Gabriel Levy-Hara,Jasper Littman,Surbhi Malhotra-Kumar,Vikas Manchanda,Lorenzo Moja,Babacar Ndoye,Angelo Pan,David L. Paterson,Mical Paul,Haibo Qiu,Pilar Ramon-Pardo,Jesús Rodríguez-Baño,Maurizio Sanguinetti,Sharmila Sengupta,Mike Sharland,Massinissa Si-Mehand,Lynn L. Silver,Wonkeung Song,Martin Steinbakk,Jens Thomsen,Guy E. Thwaites,Jos W. M. van der Meer,Nguyen Van Kinh,Silvio Vega,Maria Virginia Villegas,Agnes Wechsler-Fördös,Heiman F. L. Wertheim,Evelyn Wesangula,Neil Woodford,Fidan O Yilmaz,Anna Zorzet +81 more
TL;DR: Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria, and include antibiotic-resistant bacteria responsible for community-acquired infections.
Journal ArticleDOI
Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study
Mikhail V. Edelstein,Elena N. Skleenova,Oksana V. Shevchenko,Jimson W. D'souza,Dmitry V. Tapalski,Ilya Azizov,Marina V. Sukhorukova,Roman A. Pavlukov,Roman S. Kozlov,Mark Toleman,Timothy R. Walsh +10 more
TL;DR: Extensively-drug-resistant ST235 P aeruginosa has rapidly spread throughout Russia and into Belarus and Kazakhstan via clonal dissemination.
Journal ArticleDOI
Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy.
Igor A. Guchev,Victor L. Yu,A. I. Sinopal’nikov,Oleg I. Klochkov,Roman S. Kozlov,Leonid S. Stratchounski +5 more
TL;DR: The urine antigen test allowed targeted use of a penicillin (amoxicillin) for young immunocompetent individuals with nonsevere, community-acquired pneumonia.
Journal ArticleDOI
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed
Mark S. Butler,Valeria Gigante,Hatim Sati,Sarah Paulin,Laila Al-Sulaiman,John H. Rex,Prabhavathi Fernandes,Cesar A. Arias,Mical Paul,Guy E. Thwaites,Lloyd George Czaplewski,Richard A. Alm,Christian Lienhardt,Melvin Spigelman,Lynn L. Silver,Norio Ohmagari,Roman S. Kozlov,Stéphan Juergen Harbarth,Peter Beyer +18 more
TL;DR: Future antibacterial research and development (R&D) should focus on the development of innovative and clinically differentiated candidates that have clear and feasible progression pathways to the market, especially against critical-priority pathogens.
Journal ArticleDOI
Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia.
Sofia Ny,Sofia Ny,Petra Edquist,Uga Dumpis,Kirsi Gröndahl-Yli-Hannuksela,Julia Hermes,Anna-Maria Kling,Anja Klingeberg,Roman S. Kozlov,Owe Källman,Danuta O Lis,Monika Pomorska-Wesołowska,Mara Saule,Karin Tegmark Wisell,Jaana Vuopio,Ivan Palagin +15 more
TL;DR: Low AMR rates were detected against the first-line antibiotics recommended in national UTI treatment guidelines, giving support to their future use and supporting the European Association of Urology guidelines stating that nitrofurantoin, fosfomycin and mecillinam are viable treatment options for uncomplicated UTI.